Department of Global Health - Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands; Division of Infectious Diseases and Center for Experimental and Molecular Medicine (CEMM), Department of Medicine, Amsterdam University Medical Center, Academic Medical Center, Amsterdam, The Netherlands.
Division of Infectious Diseases, Department of Medicine, Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St Louis, MO, USA; Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Trends Microbiol. 2022 Aug;30(8):778-792. doi: 10.1016/j.tim.2022.01.007. Epub 2022 Feb 6.
The interferon (IFN) response is the major early innate immune response against invading viral pathogens and is even capable of mediating sterilizing antiviral immunity without the support of the adaptive immune system. Cumulative evidence suggests that the gut microbiota can modulate IFN responses, indirectly determining virological outcomes. This review outlines our current knowledge of the interactions between the gut microbiota and IFN responses and dissects the different mechanisms by which the gut microbiota may alter IFN expression to diverse viral infections. This knowledge offers a basis for translating experimental evidence from animal studies into the human context and identifies avenues for leveraging the gut microbiota-IFN-virus axis to improve control of viral infections and performance of viral vaccines.
干扰素(IFN)反应是针对入侵病毒病原体的主要早期先天免疫反应,甚至在没有适应性免疫系统支持的情况下也能够介导杀菌性抗病毒免疫。累积证据表明,肠道微生物组可以调节 IFN 反应,间接决定病毒学结果。本综述概述了我们目前对肠道微生物组与 IFN 反应之间相互作用的了解,并剖析了肠道微生物组可能通过不同机制改变 IFN 表达以应对各种病毒感染的方式。这些知识为将动物研究的实验证据转化为人类背景提供了基础,并确定了利用肠道微生物组-IFN-病毒轴来改善病毒感染控制和病毒疫苗性能的途径。